|
| Analyst
Scorecard | | Analyst: | Sendek, Joel | EPS
Est. Accuracy: | 
| | Broker: | Lazard Capital Markets | Recommendation
Performance: | Not Avl.
|
|
What is this?
This scorecard presents a summary of StarMine ratings
for this analyst.
Ratings are displayed when analysts score highly based
on the accuracy of
their earnings estimates or the returns of their stock
recommendations. Stocks
which appear on this scorecard are limited to those
covered by the analyst for
a significant period of time. Learn
More
|
| |
Industry Coverage
| | |
Industry
|
EPS Est. Accuracy
|
Industry Excess Return
|
Industry Return
| | | |
Biotechnology
|
|
4.9%
| Not Avl.
| | | |
| |
EPS Estimate Accuracy
| | |
Symbol
|
Company Name
|
EPS Est. Accuracy
|
No. Analysts
| | | |
ACOR
|
Acorda Therapeutics Inc
| 
|
12
| | | | |
AMGN
|
Amgen Inc
|
|
21
| | | | |
ARQL
|
Arqule Inc
|
|
5
| | | | |
BIIB
|
Biogen Idec Incorporated
|
|
21
| | | | |
CBST
|
Cubist Pharmaceuticals Inc
|
|
12
| | | | |
CYTK
|
Cytokinetics Inc
|
|
5
| | | | |
DNDN
|
Dendreon Corp
|
|
12
| | | | |
EXEL
|
Exelixis
|
|
9
| | | | |
GERN
|
Geron Corporation
|
|
6
| | | | |
GILD
|
Gilead Sciences Inc
|
|
22
| | | | |
GTXI
|
Gtx Inc
|
|
6
| | | | |
IMGN
|
Immunogen Inc
|
|
6
| | | | |
INHX
|
Inhibitex Inc
|
|
3
| | | | |
OSIP
|
Osi Pharmaceuticals Inc
|
|
15
| | | | |
OSIR
|
Osiris Therapeutics Inc
|
|
5
| | | | |
PGNX
|
Progenics Pharmaceuticals
|
|
5
| | | | |
SNTA
|
Synta Pharmaceuticals Corp
|
|
5
| | | | |
THLD
|
Threshold Pharmaceuticals Inc
|
|
1
| | | | |
TRBN
|
Trubion Pharmaceuticals Inc
|
|
2
| | | | |
VPHM
|
Viropharma Inc
|
|
12
| | | |
| Other Stocks Covered
| |
Affymax Inc (AFFY), Celgene Corporation (CELG), Poniard Pharmaceuticals Inc (PARD), Pdl Biopharma Inc (PDLI)
|
| | |
|
|
|